Skip to content

Expiring federal contract

W81K0025CA001 — Nova Biomedical Corp

Department of Defense · Department of the Army

Contract / PIID
W81K0025CA001
Incumbent
Nova Biomedical Corp
Incumbent UEI
LCFDHTGXB5J3
Current end date
December 31, 2026
Potential total value
$335,697
Obligated
$335,697
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
PSC
6550 — IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Set-aside
Full & Open
Start date
January 1, 2025
Place of performance
TX
Award type
DEFINITIVE CONTRACT

Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.

What the contract covers

STATSTRIP TESTING SUPPLIES AND MONITORS

Likely rebid window (estimate)

  • Sources Sought / RFI: about Dec 2025 – Jun 2026 (6–12 months before the end date)
  • RFP: about Aug 2026 – Oct 2026 (2–4 months before the end date)

In the final months before the current end date.

Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.

Track this recompete free

  • Change history: no changes recorded since Mindy began tracking this contract.
  • Alerts: get an email when the end date moves or the follow-on is posted.
  • Contacts: the buying office and small-business contacts for this agency.

Other contracts expiring at Department of Defense (NAICS 325413)